13F-HR filed by HARVARD MANAGEMENT CO INC
HARVARD MANAGEMENT CO INC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 18 holding rows worth $459,195,000.
- Accession
- 0000950123-20-009057
- Filer
- CIK 1082621
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 18 entries on the cover page, a total value of $459,195,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $459,195,000 with VALUE read as thousands by filing date, 13F file number 028-03879. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Uber Technologies | 90353T100 | COM | 3,112,186 | $96,727,000 | thousands by filing date | |
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 63,148 | $89,547,000 | thousands by filing date | |
| PALO ALTO NETWORKS INC | 697435105 | COM | 342,612 | $78,688,000 | thousands by filing date | |
| META PLATFORMS INC CL A | 30303M102 | COM | 169,783 | $38,553,000 | thousands by filing date | |
| SPDR GOLD TR | 78463V107 | GOLD SHS | 132,372 | $22,155,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 670,382 | $21,164,000 | thousands by filing date | |
| ISHARES TR CORE S&P 500 ETF | 464287200 | SHS | 63,763 | $19,747,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 562,379 | $18,255,000 | thousands by filing date | |
| INVESCO QQQ TR | 46090E103 | COM | 65,673 | $16,261,000 | thousands by filing date | |
| NUCANA PLC | 67022C106 | ADR | 2,888,311 | $15,626,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 506,273 | $10,632,000 | thousands by filing date | |
| Vanguard FTSE Developed Markets ETF | 921943858 | SHS | 232,738 | $9,028,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 410,714 | $7,512,000 | thousands by filing date | |
| IJH | 464287507 | COM | 22,266 | $3,959,000 | thousands by filing date | |
| iShares Core S&P Small-Cap ETF | 464287804 | SHS | 52,998 | $3,619,000 | thousands by filing date | |
| VWO | 922042858 | SHS | 78,199 | $3,097,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 332,610 | $2,498,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 31,869 | $2,127,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-20-009057 | this filing | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-20-009824 | added | 2020-09-18 | acceptance time not in the bulk data set |